Standard Biotools Stock Forecast - Naive Prediction

LAB Stock  USD 1.60  0.02  1.23%   
The Naive Prediction forecasted value of Standard Biotools on the next trading day is expected to be 1.27 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.52. Standard Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Standard Biotools stock prices and determine the direction of Standard Biotools's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Standard Biotools' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
The current year's Asset Turnover is expected to grow to 0.50, whereas Inventory Turnover is forecasted to decline to 2.01. . The current year's Common Stock Shares Outstanding is expected to grow to about 83.1 M, whereas Net Loss is projected to grow to (162.5 M).

Standard Biotools Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Standard Biotools' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2007-12-31
Previous Quarter
269.8 M
Current Value
210.6 M
Quarterly Volatility
54.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Standard Biotools is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Standard Biotools value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Standard Biotools Naive Prediction Price Forecast For the 25th of November

Given 90 days horizon, the Naive Prediction forecasted value of Standard Biotools on the next trading day is expected to be 1.27 with a mean absolute deviation of 0.09, mean absolute percentage error of 0.01, and the sum of the absolute errors of 5.52.
Please note that although there have been many attempts to predict Standard Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Standard Biotools' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Standard Biotools Stock Forecast Pattern

Backtest Standard BiotoolsStandard Biotools Price PredictionBuy or Sell Advice 

Standard Biotools Forecasted Value

In the context of forecasting Standard Biotools' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Standard Biotools' downside and upside margins for the forecasting period are 0.02 and 5.23, respectively. We have considered Standard Biotools' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.60
1.27
Expected Value
5.23
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Standard Biotools stock data series using in forecasting. Note that when a statistical model is used to represent Standard Biotools stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria113.8837
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0905
MAPEMean absolute percentage error0.0491
SAESum of the absolute errors5.5219
This model is not at all useful as a medium-long range forecasting tool of Standard Biotools. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Standard Biotools. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Standard Biotools

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Standard Biotools. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.081.595.56
Details
Intrinsic
Valuation
LowRealHigh
0.050.984.95
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.06-0.05-0.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Standard Biotools. Your research has to be compared to or analyzed against Standard Biotools' peers to derive any actionable benefits. When done correctly, Standard Biotools' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Standard Biotools.

Other Forecasting Options for Standard Biotools

For every potential investor in Standard, whether a beginner or expert, Standard Biotools' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Standard Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Standard. Basic forecasting techniques help filter out the noise by identifying Standard Biotools' price trends.

Standard Biotools Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Standard Biotools stock to make a market-neutral strategy. Peer analysis of Standard Biotools could also be used in its relative valuation, which is a method of valuing Standard Biotools by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Standard Biotools Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Standard Biotools' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Standard Biotools' current price.

Standard Biotools Market Strength Events

Market strength indicators help investors to evaluate how Standard Biotools stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Standard Biotools shares will generate the highest return on investment. By undertsting and applying Standard Biotools stock market strength indicators, traders can identify Standard Biotools entry and exit signals to maximize returns.

Standard Biotools Risk Indicators

The analysis of Standard Biotools' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Standard Biotools' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting standard stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:
Check out Historical Fundamental Analysis of Standard Biotools to cross-verify your projections.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
0.558
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.15)
Return On Equity
(0.37)
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.